From Crisis to Victory: How Smart Outsourcing Is Fueling Biotech/Pharma's Recovery - CompletePhase Webinar

From Crisis to Victory: How Smart Outsourcing Is Fueling Biotech/Pharma's Slow and Steady Recovery

Is Biotech Finally Turning the Corner?

After a turbulent 2025 marked by layoffs, funding shortfalls, and clinical trial slowdowns, early 2026 is showing signs of a cautious but meaningful recovery. Investor interest is returning, especially in platforms that integrate AI ... but capital remains measured, and operational decisions are under greater scrutiny than ever.

In this timely webinar, industry leaders discuss how strategic outsourcing is helping biotech and pharma teams navigate uncertainty, regain momentum, and stretch budgets further, all without compromising quality or timelines.

Register for Webinar

Date: Wednesday, March 4, 2026

Time: 1:00 PM PT / 4:00 PM ET

Location: Live Online

Cost: Free Registration

What You'll Learn

The current state of biotech investment and clinical trial activity in 2026

How companies are allocating capital between AI innovation and clinical execution

Why outsourcing is becoming a strategic priority, not just a cost-saving measure

A real-world case study: How one biotech accelerated timelines and reduced risk by partnering with Complete Phase

Who Should Attend

Clinical operations leaders at biotechs and emerging pharma companies

R&D and program directors overseeing Phase I–III trials

Business development, outsourcing, and strategic partnership leads

Investors and consultants navigating biotech's 2026 recovery

Featured Speaker

Negin Rahmani

Founder, Complete Phase

Clinical operations leader with extensive U.S. and APAC experience

About Complete Phase

Complete Phase is a clinical trial partner headquartered in Australia, with a growing U.S. presence. Our team delivers full-service support across early and late-phase trials, combining global agility with deep regional expertise. We serve sponsors who need experienced, flexible, and cost-effective execution—without sacrificing quality.

This session is part of our 2026 U.S. expansion series for biotech and pharma leaders seeking resilient, forward-thinking clinical trial strategies.

Don't Miss This Critical Discussion

Join us on Wednesday, March 4, 2026 at 1:00 PM PT / 4:00 PM ET to learn how strategic outsourcing is helping biotech and pharma teams navigate today's challenges and position for tomorrow's opportunities.